Engineering Chemokines to Develop Optimized HIV Inhibitors

E-ISSN： 1875-5550|6|3|207-219

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.6, Iss.3, 2005-01, pp. : 207-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis 2,3

By Bautista A.P.

Free Radical Biology and Medicine, Vol. 31, Iss. 12, 2001-12 ,pp. : 1527-1532

Elsevier

Access to resources Recommend Favorite

Synthesis and Primary Evaluation of Novel HIV-1 Inhibitors

By Safadi Yazan El Marquet Roland Aubertin Anne-Marie Vivet-Boudou Valérie

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1161-1165

Taylor & Francis Ltd

Access to resources Recommend Favorite

Peptide nucleic acids as epigenetic inhibitors of HIV-1

By Shizuko Sei

Letters in Peptide Science, Vol. 10, Iss. 3-4, 2003-01 ,pp. : 269-286

Springer Publishing Company

Access to resources Recommend Favorite

The strand transfer oligonucleotide inhibitors of HIV-integrase

By Snasel Jan Rosenberg Ivan Paces Ondrej Pichova Iva

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. : 241-246

Informa Healthcare

Access to resources Recommend Favorite

Triterpenes as Potential Dimerization Inhibitors of HIV-1 Protease

By Quere L. Wenger T. Schramm H.J.

Biochemical and Biophysical Research Communications, Vol. 227, Iss. 2, 1996-10 ,pp. : 484-488

Elsevier

Access to resources Recommend Favorite